BCL2 and ovarian cancer: And in the study on the effects of theaflavin‐3 (TF3) on ovarian cancer cell DDP‐resistance conducted by Tu et al,17 the cisplatin resistance of ovarian cancer cells was drastically enhanced after treatment with proteins of the Bcl‐2 family.